SLC44A4 and infection: This discrepancy was not observed in the low P. falciparum infection intensity assay (Fig 2D) nor in P. berghei infection assays (Fig 2A and 2B), suggesting that CRISPR/Cas9-mediated disruption of CTL4 also results in the killing of P. falciparum without the formation of a melanotic capsule at high infection intensity.